相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant Recipients
Jillian L. Descourouez et al.
ANNALS OF PHARMACOTHERAPY (2023)
Low-Dose Valganciclovir Prophylaxis Is Safe and Cost-Saving in CMV-Seropositive Kidney Transplant Recipients
Yiyun Shi et al.
PROGRESS IN TRANSPLANTATION (2021)
Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin
Mario Fernandez-Ruiz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+and CD8+T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
Ralph Rogers et al.
BMC INFECTIOUS DISEASES (2020)
CMV cell-mediated immunity assays: Focus on CD4+ cells
Alexis H. Lerner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Prediction of cytomegalovirus infection: A single-center experience utilizing a newly available cell-mediated immunity assay by flow cytometry, a risk factor screening tool, and serologically demonstrated immunity
Margaret R. Jorgenson et al.
TRANSPLANT INFECTIOUS DISEASE (2020)
Potential mortality benefit from secondary prophylaxis following CMV treatment completion may be due to confounding by transplant organ type
Bradley J. Gardiner et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
A Randomized Study of Quantiferon CMV-directed Versus Fixed-duration Valganciclovir Prophylaxis to Reduce Late CMV After Lung Transplantation
Glen P. Westall et al.
TRANSPLANTATION (2019)
Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation A PRISMA-compliant article
Yashi Ruan et al.
MEDICINE (2019)
Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic's First Face Transplant
Raymund R. Razonable et al.
MAYO CLINIC PROCEEDINGS (2019)
A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients
Deepali Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
Dominika Deborska-Materkowska et al.
BMC INFECTIOUS DISEASES (2018)
Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection
Angela Chiereghin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients
Smaranda Gliga et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study
Dimitrios Chanouzas et al.
PLOS ONE (2018)
Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation
M. Serrano-Alonso et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Early viral-specific T-cell testing predicts late cytomegalovirus reactivation following liver transplantation
S. Sood et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based invitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Bernhard Banas et al.
TRANSPLANT INTERNATIONAL (2018)
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2018)
CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D plus /R plus Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy
Marta Jarque et al.
TRANSPLANTATION (2018)
CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor
Thomas Schachtner et al.
TRANSPLANTATION (2017)
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant. Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience
E. Favi et al.
TRANSPLANTATION PROCEEDINGS (2017)
T-Cell Immunity Panel Measures CMV-Specific CD4 and CD8 T-Cell Responses
Cory B Lutgen et al.
Open Forum Infectious Diseases (2017)
Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease
M. Veronica Dioverti et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients
Bradley J. Gardiner et al.
CLINICAL INFECTIOUS DISEASES (2017)
Rhomboid glossitis in disseminated CMV infection
Robert C. Black et al.
IDCASES (2017)
An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation
D. Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation
F. Leone et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real-time PCR findings in apparently immunocompetent patients: a case series
S. Bernard et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review
Ella J. Ariza-Heredia et al.
CANCER LETTERS (2014)
Evaluation of CMV-specific cellular immune response by EliSPOT assay in kidney transplant patients
Cristina Costa et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients
Elisa Gabanti et al.
PLOS ONE (2014)
Cytomegalovirus in Solid Organ Transplantation
R. R. Razonable et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
Oriol Manuel et al.
CLINICAL INFECTIOUS DISEASES (2013)
Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients
Davide Abate et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Human Cytomegalovirus-Specific T-Cell Immune Reconstitution in Preemptively Treated Heart Transplant Recipients Identifies Subjects at Critical Risk for Infection
Davide Abate et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis
A. P. Wiita et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia
Luiz F. Lisboa et al.
TRANSPLANTATION (2012)
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Cytomegalovirus Reinfections in Healthy Seroimmune Women
Shannon A. Ross et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
D. Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Tania Crough et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil
S. Brurn et al.
TRANSPLANTATION PROCEEDINGS (2008)
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON (R)-CMV
S. Walker et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Infectious complications associated with alemtuzumab use for lymphoproliferative disorders
Stanley I. Martin et al.
CLINICAL INFECTIOUS DISEASES (2006)
Memory CD8 T-cell differentiation during viral infection
EJ Wherry et al.
JOURNAL OF VIROLOGY (2004)
Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation
GA Knoll et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
分享论文
